Business news for the stock market

Nexus AG: Half-Year Report 2021

Very strong sales and earnings increase in the first Half-Year 2021

Donaueschingen (pta012/05.08.2021/08:30 UTC+2)

Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 17% and EBIT by approx. 20% in the first six months of 2021. As a result, the continually positive development of sales and earnings of the last years could be continued.

Sales improved from KEUR 77,659 to KEUR 90,857 (+17.0%) in the first half-year 2021. The international share of total business volume was 46.6% (6M 2020: 44.1%) and amounted to KEUR 42,320 compared to KEUR 34,267 (6M-2020).

The consolidated surplus rose very sharply by 22.2% to KEUR 7,580 (6M 2020: KEUR 6,201), and consolidated earnings before interest and taxes (EBIT) rose by 19.9% to KEUR 10,147 (6M 2020: KEUR 8,462): EBITA increased by 18.8% from KEUR 10,375 (6M-2020) to KEUR 12,329, and EBITDA increased by 10.4% to KEUR 18,391 (6M 2020: KEUR 16,663).

Operating cash flow increased by 3.8% to KEUR 27,070 in the first six months (6M-2020: KEUR 26,081) and remains at a very high level. As of 30/06/2021, the company had cash resources at its disposal in the amount of KEUR 29,553 (31/12/2020: KEUR 28,177). Nexus AG had equity capital amounting to KEUR 128,800 as of 30/06/2021 (31/12/2020: KEUR 123,583). Consequently, the equity capital rate is 50.9% (31/12/2020: 55.4%). This demonstrates that Nexus AG has a sustainable and healthy balance sheet as well as sufficient capital for further financing of its European growth strategy.

Donaueschingen, 05.08.2021


The Managing Board


Emitter: Nexus AG
Irmastraße 1
78166 Donaueschingen
Contact Person: Hannes Wehinger
Phone: +49 771 22960-260
ISIN(s): DE0005220909 (Share)
Stock Exchange(s): Regulated Market in Frankfurt, Hamburg; Free Market in Berlin, Dusseldorf, Munich, Stuttgart